2021 annual financial data
XORTX Therapeutics 2021 Operating cash flow
XORTX Therapeutics 2021 operating cash flow with verified reported values.
Direct answer
Operating cash flow was -4,801,045 CAD.
Operating income was -2,902,877 CAD and net income was -1,652,282 CAD.
Operating cash flow was -4,801,045 CAD.
Get free XORTX Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -2,902,877 CAD
- Net income
- -1,652,282 CAD
- Operating cash flow
- -4,801,045 CAD